key: cord-0687064-mhwdzoim
authors: Shoar, Saeed
title: ICU Admission and Outcome of Patients with COVID-19: Does ICU Stay Improve Survival?
date: 2021-01-26
journal: Heart Lung
DOI: 10.1016/j.hrtlng.2021.01.017
sha: 821d41144e2c1ba6d927110b731219a2f15b8863
doc_id: 687064
cord_uid: mhwdzoim

nan

There is no conflict of interest in any forms.

No funds have been received in any forms.

The value of an intensive care unit (ICU) bed has never been appreciated more than over the last year. With the extreme strain that the global healthcare system beard due to the overwhelming burden of COVID-19 pandemic, the decision to allocate the limited number of ICU beds to patients who are critically ill due to COVID-19 or as a result of other underlying comorbidities have been the most complex one to make 1 . This is particularly important in nations with limited resources or healthcare personnel per admitted patient.

In the January issue of Heart & Lung in 2021, Namendys-Silva et al. published their observation of 164 patients with COVID-19 who were admitted to the ICU of ten hospitals in Mexico 2 .

Comparing the data between survivors and non-survivors, the study demonstrated age and elevated level of C-reactive protein (CRP) to be significantly associated with a higher risk of mortality in ICU patients with COVID-19. Furthermore, the study showed an association between lengthen ICU stay and reduced in-hospital mortality. Although the study has used a multivariable regression model to estimate the odds ratio of mortality determinants and an area under the receiver operating curve to evaluate the generalizability of the model, few questions remain to be answered.

Out of 164 patients with COVID-19 who were admitted to the ICU, the infection with SARS-CoV-2 has been microbiologically-confirmed in 15.9% of the cases. The question is how those with no microbiological testing were diagnosed to have COVID-19. That being said, one might be interested in analyzing the data of survivors and non-survivors in two subgroups of patients with and without microbiological confirmatory testing for SARS-CoV-2.

Another aspect of survival assessment in hospitalized patients with COVID-19 is the timing from symptom onset to the presentation at ED, admission to the ICU, and receiving mechanical ventilation 3 . The study depicts a series of timing including a median of 7 days from symptom onset toward presentation to the hospital, a median of 11 days for ICU stay, a median of 12 days of mechanical ventilation, and a median of 13 days for hospital stay. There was a difference in the duration of in-hospital courses between survivors and non-survivors. We have shown that a dropped oxygen saturation at the hospital admission are associated with an increased mortality in patients with COVID-19 3 . It would be interesting to know if such a pattern was also observed in this cohort, especially that all the patients ultimately required invasive mechanical ventilation.

The other parameter that is of potential interest in this context is the timing from presentation at the emergency department to the ICU admission 1 . Although the duration of symptoms before triaging at the ED was similar between survivors and non-survivors, did a shorter timeframe to the ICU admission increase the mortality rate? The answer to this question can also shed some light on the authors' conclusion that an increased length of ICU stay was associated with lower risk of in-hospital mortality. One might also ask if a retrospective cohort can estimate a risk ratio due to its inherent limitations.

In summary, the small sample size of the current cohort precludes it to be conclusive on variables, which have been previously demonstrated as a risk factor for disease severity, ICU admission, and death in patients with COVID-19. Men, elderlies, chronic obstructive pulmonary diseases, and current smokers are few to mention 3, 4 .

Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores

Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study

Meta-analysis of Cardiovascular Events and Related Biomarkers Comparing Survivors Versus Non-survivors in Patients With COVID-19

Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies